53 related articles for article (PubMed ID: 29393284)
1. Current and Perspective Approaches to the Treatment of Prolactinomas.
Tykhonova T; Barabash N; Kanishcheva O
Acta Med Litu; 2023; 30(2):96-107. PubMed ID: 38516518
[TBL] [Abstract][Full Text] [Related]
2. Neuroendoscopic Transnasal Repair of Cerebrospinal Fluid Rhinorrhea.
Husain M; Jha D; Vatsal DK; Husain N; Gupta RK
Skull Base; 2003 May; 13(2):73-78. PubMed ID: 15912162
[TBL] [Abstract][Full Text] [Related]
3. Medically responsive amyloidogenic giant sellar-parasellar prolactinoma.
Singh AK; Shilpi ; Kumari G; Tangri R
Surg Neurol Int; 2024; 15():129. PubMed ID: 38741982
[TBL] [Abstract][Full Text] [Related]
4. Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: An observational study in Algerian population.
Chentli F; Azzoug S; Daffeur K; Akkache L; Zellagui H; Haddad M; Kalafate N
Indian J Endocrinol Metab; 2015; 19(3):359-63. PubMed ID: 25932390
[TBL] [Abstract][Full Text] [Related]
5. Rhinorrhea from a cerebrospinal fluid fistula.
Grau Mirete B; Fernández Martínez MÁ
Emergencias; 2023 Aug; 35(4):320. PubMed ID: 37439433
[No Abstract] [Full Text] [Related]
6. Spontaneous cerebrospinal fluid rhinorrhea: A case report and analysis: Erratum.
Medicine (Baltimore); 2018 Mar; 97(12):e0274. PubMed ID: 29561458
[No Abstract] [Full Text] [Related]
7. Letter to the Editor from Andereggen and Christ: "Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study".
Andereggen L; Christ E
J Clin Endocrinol Metab; 2024 Jun; ():. PubMed ID: 38843072
[No Abstract] [Full Text] [Related]
8. Response to Letter to the Editor from Andereggen and Christ: "Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study".
Wang L; Zhu H
J Clin Endocrinol Metab; 2024 Jun; ():. PubMed ID: 38843073
[No Abstract] [Full Text] [Related]
9. Efficacy and Cerebrospinal Fluid Rhinorrhea after Cabergoline Treatment in Patients with Bioactive Macroprolactinoma.
Kim HK; Hong JW; Moon JH; Ahn SS; Kim EH; Lee SK; Lee EJ; Park YW; Ku CR
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771538
[TBL] [Abstract][Full Text] [Related]
10. Medically induced CSF rhinorrhea following treatment of macroprolactinoma: case series and literature review.
Česák T; Poczos P; Adamkov J; Náhlovský J; Kašparová P; Gabalec F; Čelakovský P; Choutka O
Pituitary; 2018 Dec; 21(6):561-570. PubMed ID: 30116971
[TBL] [Abstract][Full Text] [Related]
11. [Complications of treatment of prolactinoma by dopamine agonists].
Astaf'eva LI; Kadashev BA; Kutin MA; Kalinin PL
Zh Vopr Neirokhir Im N N Burdenko; 2011; 75(2):41-50; discussion 50. PubMed ID: 21793295
[TBL] [Abstract][Full Text] [Related]
12. [Cerebrospinal fluid rhinorrhea in primary treatment of large and giant prolactinomas with dopamine agonists].
Kalinin PL; Shkarubo AN; Astafieva LI; Chernov IV; Ismailov DB; Kadashev BA; Fomichev DV; Kutin MA; Sharipov OI; Andreev DN; Fomochkina LA
Zh Vopr Neirokhir Im N N Burdenko; 2017; 81(6):32-39. PubMed ID: 29393284
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous cerebrospinal fluid rhinorrhea in untreated macroprolactinoma--an indication for primary surgical therapy.
Honegger JB; Psaras T; Petrick M; Beuschlein F; Reincke M
Zentralbl Neurochir; 2006 Aug; 67(3):149-54. PubMed ID: 16958013
[TBL] [Abstract][Full Text] [Related]
14. Prolactinoma extension as a contributing factor in dopamine agonist-induced CSF rhinorrhea: a systematic review of the literature.
Milton CK; Lee BJ; Voronovich ZA; Conner AK; McKinney KA; El Rassi ET; Lim J; Glenn CA
Br J Neurosurg; 2023 Oct; 37(5):976-981. PubMed ID: 33783287
[TBL] [Abstract][Full Text] [Related]
15. Treatment Strategy for Giant Invasive Macroprolactinoma with Spontaneous Cerebrospinal Fluid Rhinorrhea: A Case Report and Literature Review.
Abe D; Ogiwara T; Nakamura T; Ichinose S; Fujii Y; Hanaoka Y; Ito K; Horiuchi T
World Neurosurg; 2020 Dec; 144():19-23. PubMed ID: 32853764
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
